医疗管理和内镜胆道支架与与外肝胆道阻塞手术相比更好的结果相关的狗
Jay Pakhawala1, Allyson Berent2, Chick Weisse2
11Department of Internal Medicine, The Schwarzman Animal Medical Center, New York, NY.
Journal of the American Veterinary Medical Association
|February 11, 2026
概括
医疗管理和内镜逆行胆血管学 (ERC) 辅助胆管支架为患有肝外胆道阻塞 (EHBO) 的狗提供了比手术更好的结果. 这些方法提供了更安全的替代方案,改善了生存率和更少的并发症.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 胃肠病学 胃肠病学
- 手术瘤学手术瘤学
背景情况:
- 肝外胆道阻塞 (EHBO) 是狗的一种严重疾病.
- 对于EHBO的治疗选择包括医疗管理,内镜逆行胆道血管学 (ERC) 辅助胆道支架和手术减压.
- 这些不同的治疗方式的结果和并发症率尚未全面比较.
研究的目的:
- 为了比较EHBO治疗的狗的短期和长期临床结果,用医疗管理,ERC辅助胆道支架或手术治疗.
- 评估不同治疗组的生存率和并发症发生率.
主要方法:
- 追溯审查28只被诊断患有EHBO的狗的医疗记录.
- 狗被按治疗方式分组:医疗管理 (10),ERC辅助胆道支架 (12),或手术 (6).
- 评估结果包括存活到出院的时间,中位数存活时间和并发症.
主要成果:
- 医疗组的存活率为100%,ERC的92%和手术组的33%.
- 医疗或ERC组的中位生存时间没有达到,而手术的平均生存时间为4天.
- ERC取得了86%的技术成功,并发症率低于手术;医疗管理往往导致自发解决.
结论:
- 与狗的EHBO手术相比,医疗管理和ERC辅助胆道支架与更好的生存率和更少的并发症有关.
- 手术干预显示死亡率和并发症率最高.
- ERC辅助支架和医疗管理是对狗EHBO进行手术的更安全的替代方案.
相关概念视频
Endocarditis III: Medical Management
266
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
266
Myocarditis III: Medical Management
221
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
221
Pericarditis III: Medical Management
370
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
370
Heart Failure V: Medical Management
360
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
360
Mitral Stenosis III: Medical Management
312
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
312
Aortic Regurgitation III: Medical Management
467
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
467


